Nonclinical Studies Subcommittee

of the Advisory Committee for Pharmaceutical Science

November 13, 2001

 

Chair

John Doull, M.D., Ph.D.

Professor Emeritus of Pharmacology and Toxicology

Department of Pharmacology and Toxicology and Therapeutics

University of Kansas Medical Center

3901 Rainbow Boulevard

Kansas City, Kansas 66160-7417

 

Executive Secretary

Nancy Chamberlin, Pharm.D.

Advisors and Consultants Staff

Center for Drug Evaluation and Research

Food and Drug Administration (HFD-21)

5600 Fishers Lane

Rockville, Maryland 20857

(301) 827-7001 Fax: (301) 827-6776

Email: chamberlinn@cder.fda.gov

 

Consumer Representative

Gloria L. Anderson, Ph.D.

Fuller F. Callaway Professor of Chemistry

Morris Brown College

643 Martin Luther King Jr. Drive, NW

Atlanta, Georgia 30314-4140

 

SGE Consultants

Jay Goodman, Ph.D.

Professor of Pharmacology

Dept.of Pharmacology and Toxicology

Michigan State University

B-440 Life Sciences Bldg.

East Lansing, MI 48824-1317

 

Joy Cavagnaro, Ph.D.

P.O. Box 1362

Leesburg, VA 20177

 

Industry Participants

Jack H. Dean, Ph.D., D.A.B.T.

President and Scientific Director Sanofi-Synthelabo

Research Division

International Director Preclinical Development

Sanofi-Synthelabo, Inc.

9 Great Valley Parkway

Malvern, Pennsylvania 19355

 

Jack H. Reynolds, D.V.M.

Vice President, Drug Safety Evaluation

Pfizer, Inc.

50 Pequot Avenue

New London, Connecticut 06340

 

 

Government Participants

David M. Essayan, M.D.

Food and Drug Administration

CBER/OTRR/DCTDA/PTB, HFM-579

Woodmont Building 1, Room 200 N

1401 Rockville Pike

Rockville, MD 20852


James T. MacGregor, Ph.D. , D.A.B.T.

Deputy Director for Washington, NCTR

Parklawn, 16-53 HFT-10

5600 Fishers Lane

Rockville, MD 20857

Raymond Tennant, Ph.D.

National Institute of Environmental Health

Sciences/ NIH

101 Alexandar Drive

Research Triangle Park, NC 27709

Daniel A. Casciano, Ph.D.

Center Director, National Center Toxicology

NCTR

Building 13, Room 122, HFT-1

3900 NCTR Drive

Jefferson, Arkansas 72029

 

Helen N. Winkle

Acting Director, Office of Pharmaceutical Science

Food and Drug Administration

CDER/OPS/HFD-003

Woodmont Building 2, Room 6008

1451 Rockville Pike

Rockville, MD 20853